本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bicara Therapeutics

10.53
-0.5800-5.22%
盘后10.530.00000.00%18:43 EDT
成交量:40.99万
成交额:439.56万
市值:5.74亿
市盈率:-3.45
高:11.17
开:10.90
低:10.50
收:11.11
数据加载中...
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

重要事件披露

Form 8-K - Current report
2025/06/06

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/26

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/26

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/18

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/11

SEC问询函

Form CORRESP - Correspondence